DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Patiromer sorbitex calciumis the generic ingredient in one branded drug marketed by Relypsa Inc and is included in one NDA. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Patiromer sorbitex calcium has one hundred and sixty-nine patent family members in twenty-four countries.
One supplier is listed for this compound.
Summary for patiromer sorbitex calcium
Pharmacology for patiromer sorbitex calcium
|Drug Class||Potassium Binder |
|Mechanism of Action||Potassium Ion Binding Activity |
Synonyms for patiromer sorbitex calcium
|Calcium, hydrolyzed divinylbenzene-Me 2-fluoro-2-propenoate-1,7-octadiene polymer sorbitol complexes|
|Cross-linked polymer of calcium 2-fluoroprop-2-enoate with diethenylbenzene and octa-1,7-diene, combination with D-glucitol|
|Patiromer sorbitex calcium [USAN]|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Relypsa Inc||VELTASSA||patiromer sorbitex calcium||POWDER;ORAL||205739-003||Oct 21, 2015||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Relypsa Inc||VELTASSA||patiromer sorbitex calcium||POWDER;ORAL||205739-002||Oct 21, 2015||RX||Yes||No||Start Trial||Start Trial||Y||Start Trial|
|Relypsa Inc||VELTASSA||patiromer sorbitex calcium||POWDER;ORAL||205739-001||Oct 21, 2015||RX||Yes||No||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2957286||PA2018016,C2957286||Lithuania||Start Trial||PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS; REGISTRATION NO/DATE: EU/1/17/1179 20170719|
|2365988||CA 2018 00006||Denmark||Start Trial||PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721|
|2269589||CA 2018 00003||Denmark||Start Trial||PRODUCT NAME: PATIROMER AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179 20170721|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.